-
Anti-Inflammatory Lignans from Rosemary Roots: New Compounds
2026-06-29
This study systematically identifies eight lignans and four phenylpropanoids from Rosmarinus officinalis roots, including three novel structures, and evaluates their anti-inflammatory effects in an LPS-stimulated macrophage model. The findings reveal new lead compounds for inflammation research and highlight previously underexplored plant root metabolites as a promising pharmacological resource.
-
Streptavidin-FITC: High-Sensitivity Biotin Detection Workflo
2026-06-28
Streptavidin-FITC from APExBIO sets the benchmark for sensitive and quantitative detection of biotinylated molecules across imaging, cytometry, and hybridization assays. Its robust performance streamlines nanoparticle tracking and immunofluorescence, while the latest research reveals new frontiers in intracellular trafficking analysis.
-
Practical Use of Palmitic Acid (Hexadecanoic Acid) in Resear
2026-06-27
Palmitic acid (hexadecanoic acid, SKU N2456) addresses the need for a high-purity saturated long-chain fatty acid in metabolic disorder research, protein palmitoylation studies, and lipid metabolism assays. It is not suitable for protocols requiring aqueous solubility or long-term solution stability, necessitating precise handling and preparation for reproducible results.
-
Distinct Apoptotic Pathways in BMECs Triggered by Candida kr
2026-06-26
Miao et al. (2023) demonstrated that the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) via distinct signaling cascades. This work highlights differential involvement of mitochondrial and death receptor pathways, as well as modulation through TLR2/ERK and JNK/ERK signaling, offering mechanistic insights relevant for mastitis research and intervention.
-
Live-Dead Cell Staining Kit: Precision in Viability Assays
2026-06-26
APExBIO’s Live-Dead Cell Staining Kit leverages Calcein-AM and Propidium Iodide dual staining for unmatched discrimination of live and dead cells in drug cytotoxicity, biomaterials testing, and advanced viability workflows. Discover protocol enhancements, troubleshooting guidance, and how the kit outperforms legacy single-dye methods in both fluorescence microscopy and flow cytometry.
-
GSH and GSSG Assay Kit: Decoding Redox Mechanisms in Tumor B
2026-06-25
Explore how the GSH and GSSG Assay Kit enables advanced reduced glutathione detection and precise redox profiling in hypoxic tumor environments. This in-depth article reveals unique assay strategies, protocol insights, and translational relevance beyond what standard guides provide.
-
Anti Reverse Cap Analog: Optimizing mRNA Capping for Researc
2026-06-25
Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, delivers orientation-specific capping, doubling synthetic mRNA translational efficiency over conventional caps. Its robust performance accelerates workflows in mRNA therapeutics, gene editing, and advanced metabolic studies.
-
HBsAg-TBK1 Axis Suppresses Interferon and Induces Autophagy
2026-06-24
This study uncovers how hepatitis B surface antigen (HBsAg) directly manipulates TANK-binding kinase 1 (TBK1) to inhibit type I interferon signaling and induce early, incomplete autophagy. These insights reveal a new immune evasion strategy driving persistent HBV infection and highlight novel molecular targets for antiviral research.
-
Dinaciclib (SCH727965): Precision in Cell Cycle and Boundary
2026-06-23
Dinaciclib (SCH727965) from APExBIO empowers researchers to dissect cell cycle arrest, apoptosis, and tissue boundary dynamics with unprecedented specificity. Explore optimized workflows, troubleshooting strategies, and actionable insights that bridge developmental biology and cancer research.
-
Phosphotungstic Acid Negative Stain Solution: Optimizing EM
2026-06-23
APExBIO's 2% Phosphotungstic Acid Negative Stain Solution sets the benchmark for high-contrast electron microscopy of biological specimens. This article guides researchers through optimized workflows, advanced use-cases, and practical troubleshooting—bridging cutting-edge glycan-targeting research with next-generation imaging protocols.
-
ATRA Sensitizes Ovarian Cancer to PARP Inhibitors Post-Cispl
2026-06-22
This study reveals that all-trans retinoic acid (ATRA) restores sensitivity to PARP inhibitors in epithelial ovarian cancer (EOC) cells rendered resistant by cisplatin exposure. By targeting NAD+ metabolism and key resistance-associated genes, ATRA offers a mechanistically informed strategy for overcoming PARPi resistance in EOC maintenance therapy.
-
NADH in Photocatalytic Cancer Therapy and Mitochondrial Rese
2026-06-22
Reduced nicotinamide adenine dinucleotide (NADH) is indispensable for probing mitochondrial electron transport chain mechanisms and has emerged as a key substrate in next-generation photocatalytic cancer therapy. This guide synthesizes recent reference breakthroughs and practical lab workflows, highlighting APExBIO's NADH as the gold-standard reagent for robust, reproducible assays.
-
HOBt (1-Hydroxybenzotriazole): Powering High-Fidelity Peptid
2026-06-21
HOBt (1-Hydroxybenzotriazole) revolutionizes peptide and amide bond synthesis by minimizing epimerization and enabling robust workflows for challenging bioactive molecules. APExBIO’s high-purity HOBt streamlines experimental design, ensures stereochemical integrity, and delivers reproducible results for both advanced research and translational development.
-
DiR (DiIC 18 (7)): Deep-Red Imaging for Translational Precis
2026-06-20
Explore how DiR (DiIC 18 (7)) enables next-generation live and fixed membrane imaging, delivers mechanistic insight for cell tracking and EV therapy, and bridges the gap from preclinical innovation to clinical translation in regenerative medicine and targeted nanomedicine workflows.
-
PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied
2026-06-19
PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect protein degradation and immune pathways in both infection and inflammation models. This article translates the latest mechanistic findings from the viral immunology field into actionable experimental workflows and troubleshooting strategies using PYR-41 from APExBIO.